RecruitingNot applicableNCT06186752

Feasibility Test of Action Planning in Pediatric IBD

Studying PLA2G6-associated neurodegeneration

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of North Carolina, Chapel Hill
Principal Investigator
Neal deJong, MD, MD
UNC-Chapel Hill School of Medicine
Intervention
MyIBD(behavioral)
Enrollment
60 target
Eligibility
13-19 years · All sexes
Timeline
20242026

Study locations (1)

Collaborators

National Center for Advancing Translational Sciences (NCATS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06186752 on ClinicalTrials.gov

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

See all trials for PLA2G6-associated neurodegeneration

← Back to all trials